Literature DB >> 28930506

Tuberculosis Elimination in the United States - The Need for Renewed Action.

Ronald Bayer1, Kenneth G Castro1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28930506     DOI: 10.1056/NEJMp1707387

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Treatment of Latent Tuberculosis Infection-An Update.

Authors:  Moises A Huaman; Timothy R Sterling
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

2.  QuantiFERON-TB Gold Versus Tuberculin Screening and Care Retention Among Persons Experiencing Homelessness: Georgia, 2015-2017.

Authors:  Jeffrey M Collins; Udodirim Onwubiko; David P Holland
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

3.  Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.

Authors:  Claudia C Dobler; Sinthia Bosnic-Anticevich; Carol L Armour
Journal:  ERJ Open Res       Date:  2018-03-23

4.  Revisiting the timetable of tuberculosis.

Authors:  Marcel A Behr; Paul H Edelstein; Lalita Ramakrishnan
Journal:  BMJ       Date:  2018-08-23

5.  Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.

Authors:  Marie Nancy Séraphin; HsiaoChu Hsu; Helena J Chapman; Joanne L de Andrade Bezerra; Lori Johnston; Yang Yang; Michael Lauzardo
Journal:  BMC Public Health       Date:  2019-09-03       Impact factor: 3.295

6.  Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.

Authors:  Grace A Noppert; Ryan E Malosh; Elizabeth B Moran; Shama D Ahuja; Jon Zelner
Journal:  Curr Epidemiol Rep       Date:  2018-09-28

7.  Targeted Versus Nontargeted Communication About Electronic Nicotine Delivery Systems in Three Smoker Groups.

Authors:  Bo Yang; Jiaying Liu; Lucy Popova
Journal:  Int J Environ Res Public Health       Date:  2018-09-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.